ID 1828 - 5-hydroksytryptofan

PL: 5-hydroksytryptofan
EN: 5-HTP
Pdf: 5-hydroxytryptophan

Oświadczenie (2)

1. Charakterystyka żywności / składnika

The food constituent that is the subject of the health claim is “5-hydroxytryptophan”.
5-Hydroxytryptophan is naturally present in food and can be measured by established methods.
The Panel considers that the food constituent, 5-hydroxytryptophan, which is the subject of the health claim is sufficiently characterised.

2.2. Uwaga (ID 1828)

The claimed effect is “mental state and performance”. The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effects relate to concentration and reduction of restlessness. Concentration can be interpreted as attention which can be assessed by standard test methods. Restlessness is not a defined psychological construct.
The Panel considers that normal attention might be beneficial to human health.

3.2. Uwaga (ID 1828)

Four references were cited to substantiate the claim. All four studies addressed different types of patients with anxiety, panic and sleep disorders. The Panel considers that the evidence provided does not establish that clinically ill patients with anxiety, panic and sleep disorders are representative of the general population with regard to normal attention, or that results obtained in studies on subjects with anxiety, panic and sleep disorders can be extrapolated to normal attention in the general population.
The Panel concludes that a cause and effect relationship has not been established between the dietary intake of 5-HTP and normal attention.

Warunki i możliwe ograniczenia stosowania oświadczenia

Food supplement with 16.4-49.2 mg of L-5 hydroxytryptophan in the daily dose.